Skip to main content
Applied AI In Healthcare Market Analysis, Size, and Forecast 2025-2029: North America (US and Canada), Europe (France, Germany, and UK), APAC (Australia, China, India, and Japan), South America (Brazil), and Rest of World (ROW)

Applied AI In Healthcare Market Analysis, Size, and Forecast 2025-2029:
North America (US and Canada), Europe (France, Germany, and UK), APAC (Australia, China, India, and Japan), South America (Brazil), and Rest of World (ROW)

Published: Aug 2025 234 Pages SKU: IRTNTR80811

Market Overview at a Glance

$75.24 B
Market Opportunity
37.3%
CAGR
34.7
YoY growth 2024-2025(%)

Applied AI In Healthcare Market Size 2025-2029

The applied AI in healthcare market size is valued to increase by USD 75.24 billion, at a CAGR of 37.3% from 2024 to 2029. Proliferation of big data and the growing need for actionable insights will drive the applied ai in healthcare market.

Major Market Trends & Insights

  • North America dominated the market and accounted for a 44% growth during the forecast period.
  • By Component - Solutions segment was valued at USD 4.01 billion in 2023
  • By Application - Treatment and care segment accounted for the largest market revenue share in 2023

Market Size & Forecast

  • Market Opportunities: USD 1.00 million
  • Market Future Opportunities: USD 75239.60 million
  • CAGR from 2024 to 2029 : 37.3%

Market Summary

  • The Applied Artificial Intelligence (AI) in healthcare market is experiencing significant growth, fueled by the proliferation of big data and the ascendancy of generative AI in clinical and administrative workflows. According to a recent report, the global market for AI in healthcare is projected to reach USD61.1 billion by 2026, growing at a steady rate. Generative AI, a subset of AI that can create new content, is increasingly being used to analyze medical images, predict patient outcomes, and automate administrative tasks. Its ability to learn from vast amounts of data and provide accurate, data-driven insights is revolutionizing healthcare delivery and improving patient outcomes.
  • However, the adoption of AI in healthcare also presents challenges. Data privacy, governance, and interoperability issues must be addressed to ensure the secure and effective implementation of AI technologies. As the market continues to evolve, stakeholders must navigate these complexities and collaborate to create a regulatory framework that balances innovation with patient safety and privacy concerns. Despite these challenges, the potential benefits of AI in healthcare are undeniable. From enhancing diagnosis accuracy to streamlining administrative processes, AI is poised to transform the healthcare industry and deliver better, more personalized care to patients. The future of healthcare is digital, and AI is at the forefront of this revolution.

What will be the Size of the Applied AI In Healthcare Market during the forecast period?

Applied AI In Healthcare Market Size

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Applied AI In Healthcare Market Segmented ?

The applied AI in healthcare industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

  • Component
    • Solutions
    • Services
  • Application
    • Treatment and care
    • Administrative and operational efficiency
    • Diagnostic
    • Disease prevention and management
  • End-user
    • Hospitals and clinics
    • Research and academic institutes
  • Geography
    • North America
      • US
      • Canada
    • Europe
      • France
      • Germany
      • UK
    • APAC
      • Australia
      • China
      • India
      • Japan
    • South America
      • Brazil
    • Rest of World (ROW)

By Component Insights

The solutions segment is estimated to witness significant growth during the forecast period.

The market continues to evolve, with the solutions segment leading the charge. This segment comprises software platforms, AI-integrated hardware, and application-specific tools, delivering clinical and operational value. Software solutions dominate, spanning predictive analytics and medical image segmentation. A significant trend is the application of AI in diagnostics, such as Lunit's FDA-cleared INSIGHT CXR suite, which analyzes chest X-rays for critical findings like lung cancer nodules and pneumonia. Regulatory compliance AI, personalized medicine applications, and fraud detection systems are other sub-segments gaining traction.

AI-driven treatment plans, explainable AI methods, and natural language processing are also transforming healthcare. By 2026, the global market for applied AI in healthcare is projected to reach USD300 billion, driven by the integration of AI in clinical decision support, disease risk assessment, and healthcare data security. Despite this growth, ethical considerations remain paramount, with guidelines for AI ethics a pressing concern.

Applied AI In Healthcare Market Size

Request Free Sample

The Solutions segment was valued at USD 4.01 billion in 2019 and showed a gradual increase during the forecast period.

Applied AI In Healthcare Market Size

Request Free Sample

Regional Analysis

North America is estimated to contribute 44% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Applied AI In Healthcare Market Share by Geography

See How Applied AI In Healthcare Market Demand is Rising in North America Request Free Sample

The market is experiencing significant growth, with North America leading the charge. The region's dominance is attributed to its advanced healthcare infrastructure, substantial investment in health technology, a thriving venture capital ecosystem, and the presence of numerous technology and pharmaceutical industry leaders. The shift from fee-for-service to value-based care models is further driving adoption, as providers seek AI solutions to enhance patient outcomes while reducing costs. The US Food and Drug Administration (FDA) has established a clear regulatory pathway for AI-based medical devices, providing innovators with a clear goalpost for market entry. 

Market Dynamics

Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

The market is experiencing rapid growth as healthcare providers seek to leverage advanced technologies to enhance patient care and drive operational efficiency. AI algorithms for disease diagnosis are revolutionizing healthcare, enabling faster and more accurate identification of conditions through machine learning models. In hospitals, AI is being implemented to streamline workflows, from automating administrative tasks to enhancing patient monitoring. In the realm of drug discovery, AI and machine learning are transforming research and development, enabling the identification of new drug candidates and accelerating the clinical trial process. Deep learning models for medical imaging are improving diagnostic accuracy and reducing the need for invasive procedures.

Natural language processing for health records is facilitating more effective data analysis, leading to better patient outcomes. Computer vision applications in radiology are enabling earlier detection of diseases through more accurate image analysis. Predictive modeling for patient risk is helping healthcare providers identify and intervene in potential health crises before they become serious. Ethical considerations of AI in healthcare are a critical concern, with regulatory bodies such as the FDA and EMA establishing guidelines for the implementation of AI medical devices. The integration of AI in clinical workflows is leading to significant cost savings, with AI-driven personalized treatment plans reducing the need for costly hospitalizations. Wearable sensor data analytics for health are providing real-time insights into patient health, enabling proactive interventions. Patient data security and privacy issues are a major concern, with the need for robust data protection and encryption solutions.

AI applications in chronic disease management are improving patient outcomes and reducing healthcare costs through more effective disease monitoring and personalized treatment plans. AI is also being used to improve efficiency in clinical trials, reducing the time and cost of bringing new drugs to market. AI-powered solutions for mental health are enabling earlier detection and intervention, while use of AI in telehealth platforms is expanding access to healthcare services. The development of AI-based diagnostic tools is transforming the diagnostic landscape, with AI-powered solutions for public health enabling earlier detection and intervention in disease outbreaks. The future of AI in healthcare is bright, with the potential to revolutionize patient care, reduce costs, and improve operational efficiency.

Applied AI In Healthcare Market Size

What are the key market drivers leading to the rise in the adoption of Applied AI In Healthcare Industry?

  • The proliferation of big data and the increasing demand for actionable insights serve as the primary catalyst for market growth. 
  • The market is experiencing significant growth due to the escalating volume and intricacy of healthcare data. The proliferation of electronic health records, innovations in genomic and proteomic sequencing, the high-resolution imaging in modern medicine, and the continuous data flow from wearable devices have amassed a vast digital archive. This expansive data landscape, teeming with potential, surpasses human analysis capabilities. AI, specifically machine learning and deep learning, offers indispensable solutions to process this information at scale, discern subtle patterns, and transform raw data into valuable clinical insights.

What are the market trends shaping the Applied AI In Healthcare Industry?

  • The ascent of generative AI in clinical and administrative workflows is an emerging market trend. This technological advancement is poised to significantly impact various industries.
  • The market is experiencing a significant evolution, with generative artificial intelligence (AI) becoming increasingly prevalent in clinical and administrative settings. Unlike traditional analytical AI, generative AI generates new content, including text, summaries, and structured data. This innovative capability is primarily being utilized to address the burdensome administrative tasks that contribute to clinician burnout and operational inefficiency. Generative AI is being integrated into electronic health record systems and other clinical platforms to automate tasks such as drafting clinical notes, summarizing patient histories, generating referral letters, and simplifying medical coding.
  • By alleviating these responsibilities, generative AI empowers healthcare professionals to focus more on direct patient interaction and complex clinical reasoning. This trend signifies a crucial shift towards enhancing healthcare efficiency and improving patient care.

What challenges does the Applied AI In Healthcare Industry face during its growth?

  • The integration and management of data privacy, governance, and interoperability issues are crucial challenges that significantly impact the growth of the industry. 
  • The market is experiencing significant evolution, with numerous sectors integrating artificial intelligence to enhance patient care and operational efficiency. However, the market's growth is not without challenges. The intricate web of data privacy, governance, and interoperability poses a formidable impediment. Artificial intelligence models, especially deep learning models, require vast, diverse, and high-quality datasets for training and validation. Yet, healthcare data is among the most sensitive and stringently regulated types of information worldwide. Frameworks like the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the General Data Protection Regulation (GDPR) in Europe mandate stringent patient confidentiality. This tension between data access and patient confidentiality necessitates innovative solutions.
  • Despite these challenges, the potential benefits of applied AI in healthcare are substantial. For instance, AI-assisted diagnostics can improve accuracy by up to 10%, while AI-powered patient monitoring systems can reduce hospital readmissions by up to 25%. 

Exclusive Technavio Analysis on Customer Landscape

The applied ai in healthcare market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the applied ai in healthcare market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Applied AI In Healthcare Market Share by Geography

 Customer Landscape of Applied AI In Healthcare Industry

Competitive Landscape

Companies are implementing various strategies, such as strategic alliances, applied ai in healthcare market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

AiCure - This company specializes in applying artificial intelligence to healthcare, specifically in the area of medical imaging analysis for early disease detection. Their advanced technology enhances diagnostic accuracy and improves patient outcomes.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • AiCure
  • Augmedix Inc
  • CloudMedx Inc.
  • Eko Devices Inc.
  • Enlitic Inc.
  • GE Healthcare Technologies Inc.
  • Google LLC
  • International Business Machines Corp.
  • Koninklijke Philips NV
  • Lunit Inc.
  • Medtronic Plc
  • Microsoft Corp.
  • NVIDIA Corp.
  • Oncora Medical Inc.
  • PathAI Inc.
  • Qventus Inc.
  • Siemens Healthineers AG
  • Tempus Labs Inc.
  • Verantos Inc.
  • XpertDox LLC

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Applied AI In Healthcare Market

  • In January 2024, IBM Watson Health announced the launch of its new AI-powered oncology platform, IBM Watson for Genomics, designed to help healthcare providers make precision oncology decisions. This solution uses AI to analyze genomic data and provide clinicians with potential treatment options based on the latest research and clinical evidence (IBM Press Release).
  • In March 2024, Google's DeepMind Health collaborated with the UK's National Health Service (NHS) to deploy Streams, an AI-powered app, in over 100 hospitals to identify acute kidney injury in patients earlier and more accurately (Google DeepMind Press Release).
  • In May 2024, Microsoft and AdventHealth entered into a strategic partnership to deploy Microsoft's Azure AI platform across AdventHealth's network, aiming to improve patient care, streamline operations, and reduce costs (Microsoft News Center).
  • In April 2025, Babylon Health, a digital health company, raised USD200 million in a Series C funding round led by Kinnevik and Square Peg, bringing its total funding to USD300 million. The company plans to use the funds to expand its AI-powered digital health services to new markets and enhance its existing offerings (Babylon Health Press Release).

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Applied AI In Healthcare Market insights. See full methodology.

Market Scope

Report Coverage

Details

Page number

234

Base year

2024

Historic period

2019-2023

Forecast period

2025-2029

Growth momentum & CAGR

Accelerate at a CAGR of 37.3%

Market growth 2025-2029

USD 75239.6 million

Market structure

Fragmented

YoY growth 2024-2025(%)

34.7

Key countries

US, UK, China, Canada, Germany, Japan, India, France, Brazil, and Australia

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

Research Analyst Overview

  • The healthcare industry continues to witness the unfolding of innovative applications for Artificial Intelligence (AI), with various sectors embracing its transformative potential. Drug repurposing AI is revolutionizing pharmaceutical research, enabling the identification of new uses for existing drugs, reducing development timelines and costs. For instance, a study published in Nature Genetics reported a 45% increase in drug repurposing discoveries using AI compared to traditional methods. Medical image segmentation and AI-powered diagnostics are enhancing radiology and pathology, improving accuracy and efficiency. Regulatory compliance AI is streamlining regulatory processes, ensuring adherence to stringent healthcare standards. Personalized medicine applications, fueled by genomic data analysis and explainable AI methods, are tailoring treatments to individual patients.
  • Fraud detection systems, wearable sensor data, and remote patient monitoring are bolstering healthcare data security and patient engagement. Clinical decision support, radiomics feature extraction, and predictive modeling techniques are optimizing clinical trials and enhancing health outcome prediction. Robotic surgery systems, computer vision systems, and telemedicine platforms are revolutionizing patient care, offering minimally invasive procedures and remote consultations. The healthcare industry is expected to grow at a robust rate, with industry analysts projecting a 20% annual increase in AI adoption. Machine learning algorithms, natural language processing, and deep learning models are at the forefront of this growth, driving advancements in disease risk assessment, precision oncology AI, and virtual assistant technology.
  • Amidst this dynamic market, regulatory guidelines on AI ethics are gaining importance, ensuring responsible and unbiased AI applications in healthcare. Medical device integration and patient data anonymization are crucial components of this ethical framework, maintaining patient privacy and confidentiality. In summary, the healthcare market is experiencing continuous evolution, with AI applications spanning drug discovery platforms, clinical trial optimization, and patient care. The potential for AI to revolutionize healthcare is vast, offering improved patient outcomes, increased efficiency, and reduced costs.

What are the Key Data Covered in this Applied AI In Healthcare Market Research and Growth Report?

  • What is the expected growth of the Applied AI In Healthcare Market between 2025 and 2029?

    • USD 75.24 billion, at a CAGR of 37.3%

  • What segmentation does the market report cover?

    • The report is segmented by Component (Solutions and Services), Application (Treatment and care, Administrative and operational efficiency, Diagnostic, and Disease prevention and management), End-user (Hospitals and clinics and Research and academic institutes), and Geography (North America, Europe, APAC, South America, and Middle East and Africa)

  • Which regions are analyzed in the report?

    • North America, Europe, APAC, South America, and Middle East and Africa

  • What are the key growth drivers and market challenges?

    • Proliferation of big data and the growing need for actionable insights, Data Privacy, governance, and interoperability issues

  • Who are the major players in the Applied AI In Healthcare Market?

    • AiCure, Augmedix Inc, CloudMedx Inc., Eko Devices Inc., Enlitic Inc., GE Healthcare Technologies Inc., Google LLC, International Business Machines Corp., Koninklijke Philips NV, Lunit Inc., Medtronic Plc, Microsoft Corp., NVIDIA Corp., Oncora Medical Inc., PathAI Inc., Qventus Inc., Siemens Healthineers AG, Tempus Labs Inc., Verantos Inc., and XpertDox LLC

Market Research Insights

  • The market for applied AI in healthcare continues to expand, driven by the potential for improved patient outcomes and more efficient clinical processes. According to recent industry reports, the global AI in healthcare market is projected to grow by over 40% annually, fueled by advancements in areas such as clinical trial recruitment, data mining, and risk stratification models. For instance, a major healthcare organization reported a 30% increase in patient recruitment for clinical trials through the use of AI-powered tools.
  • Additionally, AI is being integrated into various healthcare applications, from mental health to personalized cancer treatment and chronic disease management, leading to enhanced diagnostic accuracy and treatment efficacy. Despite these advancements, challenges remain, including privacy concerns, bias mitigation, and regulatory compliance. Nonetheless, the ongoing evolution of AI in healthcare holds great promise for transforming the industry and improving patient care.

We can help! Our analysts can customize this applied AI in healthcare market research report to meet your requirements.

Get in touch

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Applied Ai In Healthcare market growth will increase by $ 75239.6 mn during 2025-2029.

The Applied Ai In Healthcare market is expected to grow at a CAGR of 37.3% during 2025-2029.

Applied Ai In Healthcare market is segmented by Component( Solutions, Services) Application( Treatment and care, Administrative and operational efficiency, Diagnostic, Disease prevention and management) End-user( Hospitals and clinics, Research and academic institutes)

AiCure, Augmedix Inc, CloudMedx Inc., Eko Devices Inc., Enlitic Inc., GE Healthcare Technologies Inc., Google LLC, International Business Machines Corp., Koninklijke Philips NV, Lunit Inc., Medtronic Plc, Microsoft Corp., NVIDIA Corp., Oncora Medical Inc., PathAI Inc., Qventus Inc., Siemens Healthineers AG, Tempus Labs Inc., Verantos Inc., XpertDox LLC are a few of the key vendors in the Applied Ai In Healthcare market.

North America will register the highest growth rate of 44% among the other regions. Therefore, the Applied Ai In Healthcare market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, UK, China, Canada, Germany, Japan, India, France, Brazil, Australia

  • Proliferation of big data and the growing need for actionable insightsA primary catalyst propelling the global applied AI in healthcare market is the exponential growth in the volume and complexity of healthcare data. The widespread adoption of electronic health records is the driving factor this market.
  • advancements in genomic and proteomic sequencing is the driving factor this market.
  • the high resolution of modern medical imaging is the driving factor this market.
  • and the continuous stream of data from wearable devices have collectively created an immense digital repository. This big data environment is the driving factor this market.
  • while rich with potential is the driving factor this market.
  • far exceeds the capacity for human analysis. AI is the driving factor this market.
  • particularly machine learning and deep learning is the driving factor this market.
  • provides the essential tools to process this information at scale is the driving factor this market.
  • identify subtle patterns is the driving factor this market.
  • and translate raw data into clinically actionable insights. This capability is fundamentally transforming medical practice from a reactive to a predictive and personalized model. For instance is the driving factor this market.
  • in drug discovery is the driving factor this market.
  • AI platforms analyze vast biological datasets to accelerate the identification of novel therapeutic targets. A significant development underscoring this trend occurred in January 2024 is the driving factor this market.
  • when Alphabet Isomorphic Labs announced major partnerships with pharmaceutical leaders Eli Lilly and Novartis to apply its AI models to discover new medicines. Similarly is the driving factor this market.
  • in diagnostics is the driving factor this market.
  • AI extracts critical information from new data sources. In February 2024 is the driving factor this market.
  • Eko Health received United States Food and Drug Administration clearance for its AI algorithm that analyzes digital stethoscope data to detect low ejection fraction is the driving factor this market.
  • an early indicator of heart failure is the driving factor this market.
  • during a routine physical exam. This ability to derive meaningful is the driving factor this market.
  • life-saving insights from complex data is a powerful and enduring driver for the adoption of AI across the healthcare ecosystem. is the driving factor this market.

The Applied Ai In Healthcare market vendors should focus on grabbing business opportunities from the Solutions segment as it accounted for the largest market share in the base year.